Results for tag: "Acipimox"

Acipimox is a cardiovascular drug used to treat high levels of triglycerides in the blood. It is a nicotinic acid derivative, and works by reducing the production of triglycerides in the liver. Acipimox is available in tablet form and is usually taken twice daily. It is often used in combination with other drugs, such as statins, to reduce the risk of cardiovascular disease. Acipimox is also used to treat other conditions, such as diabetes and obesity. Acipimox is a relatively new drug, and is not widely available in many countries. It is not yet approved by the US Food and Drug Administration (FDA). However, it is approved in some European countries, such as the United Kingdom and Germany. The Acipimox market is highly competitive, with several companies offering similar products. Some of the major players in the market include Pfizer, Merck, Novartis, and Sanofi. Other companies, such as AstraZeneca, GlaxoSmithKline, and Bristol-Myers Squibb, also offer Acipimox products. Show Less Read more